OS Therapies signed agreements for the commercial manufacture of OST-HER2 as it prepares for an FDA meeting and potential BLA submission. Phase 2b data show OST-HER2 significantly improved 12-month ...
GRAFTON – Haley was a little nervous during her doctor's appointment. She shivered and cowered, but her mood quickly improved. Haley had a leg amputated nearly a year ago after a diagnosis of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback